Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...
Ozempic breasts refer to changes in breast size or shape due to weight loss from GLP-1 drugs. Here’s how and why this side ...
The Healthy on MSN14h
New Data: Nearly 50% of Weight-Loss Drug Patients Saw Lower Consumption of This, Too"For healthcare providers, these findings suggest that anti-obesity medications may offer dual benefits," one doctor reports ...
More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...
Obesity has been declared a disease by WHO. It is associated not only with heart disease, diabetes, stroke, gallstones, ...
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
With new weight-loss drugs hailed as ‘miracle’ medicines, Harriet Symonds explores whether their increasing popularity should ...
After a nurse died after just two weight-loss injections of Mounjaro - which is approved for use on the NHS - here's ...
Even when patients are aware of the risks, adherence to diet, exercise, and medication remains low—even among those who have ...
A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...
Stopping semaglutide, marketed as Wegovy and Ozempic, which helps people lose weight , can have severe health impacts, a new ...
Researchers at the University of Copenhagen have identified a promising new drug target for weight loss which could revolutionise treatment for millions of people with obesity and type 2 diabetes. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback